Both make her an invaluable addition to the team at Brigham and Women’s Hospital. She is leading a collaboration between the Interventional Cardiology Program and the Women’s Health Program to develop a protocol for evaluating cardiovascular disease in women. Dr. Leopold also works in the Cardiovascular Research Laboratory at Brigham and Women’s Hospital, where she is the Group Leader of the G6PD and Vascular Function Program. G6PD is an enzyme that is essential to blood vessel dilation, but is also vulnerable to stress. Her research may ultimately help to develop new therapies for cardiovascular and peripheral vascular disease.